title: (68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma.
authors.forename: Valentina
authors.initials: V
authors.lastname: Ambrosini
authors.forename: Maria Cristina
authors.initials: MC
authors.lastname: Marzola
authors.forename: Domenico
authors.initials: D
authors.lastname: Rubello
authors.forename: Stefano
authors.initials: S
authors.lastname: Fanti
mesh_terms: D018276:Carcinoma, Medullary / Q000000981:diagnostic imaging*; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D009942:Organometallic Compounds; D049268:Positron-Emission Tomography / Q000639:trends*; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013004:Somatostatin / Q000031:analogs & derivatives; D013961:Thyroid Gland / Q000000981:diagnostic imaging*; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging*
chemical_list: D009942:Organometallic Compounds; D019275:Radiopharmaceuticals; C043437:fluorodopa F 18; D013004:Somatostatin; D004295:Dihydroxyphenylalanine; C513399:gallium Ga 68 dotatate
references.citation: Eur J Nucl Med. 2001 Jan;28(1):64-71
references.pmid: 11202454
references.citation: Thyroid. 1999 Aug;9(8):797-804
references.pmid: 10482373
references.citation: Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):58-66
references.pmid: 19655139
references.citation: Eur J Nucl Med Mol Imaging. 2009 May;36(5):765-70
references.pmid: 19137293
references.citation: Endocr Relat Cancer. 2009 Mar;16(1):225-31
references.pmid: 19004986
references.citation: Endocr Relat Cancer. 2009 Mar;16(1):255-65
references.pmid: 19088184
references.citation: Mov Disord. 1990;5(3):203-13
references.pmid: 2117706
references.citation: Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):460-6
references.pmid: 16437218
references.citation: J Surg Oncol. 2006 Dec 15;94(8):737-47
references.pmid: 17131404
references.citation: Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1604-9
references.pmid: 17435996
references.citation: Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2120-8
references.pmid: 17661030
references.citation: Eur J Nucl Med. 2001 Nov;28(11):1671-6
references.pmid: 11702109
references.citation: Clin Endocrinol (Oxf). 1998 Mar;48(3):265-73
references.pmid: 9578814
references.citation: Eur J Nucl Med. 1998 Jan;25(1):79-83
references.pmid: 9396878
references.citation: Br J Surg. 2002 Sep;89(9):1073-5
references.pmid: 12190669
references.citation: Eur Radiol. 2009 Jun;19(6):1425-34
references.pmid: 19156423
references.citation: Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1431-8
references.pmid: 18418596
references.citation: Mol Cell Endocrinol. 2008 Sep 10;291(1-2):57-62
references.pmid: 18571834
references.citation: Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):49-57
references.pmid: 19662413
references.citation: Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):982-93
references.pmid: 17225119
references.citation: Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):72-9
references.pmid: 17874094
references.citation: Lab Invest. 1991 Apr;64(4):567-73
references.pmid: 1673164
references.citation: Semin Surg Oncol. 1991 Mar-Apr;7(2):92-9
references.pmid: 2034946
references.citation: Thyroid. 2002 Sep;12(9):747-54
references.pmid: 12481939
references.citation: Cancer Control. 2005 Oct;12(4):254-60
references.pmid: 16258498
references.citation: Q J Nucl Med Mol Imaging. 2006 Mar;50(1):78-87
references.pmid: 16557207